These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32376442)

  • 1. Sulfobutylether-β-cyclodextrin.
    Stella VJ; Rajewski RA
    Int J Pharm; 2020 Jun; 583():119396. PubMed ID: 32376442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and
    Al-Heibshy FNS; Başaran E; Öztürk N; Demirel M
    Drug Dev Ind Pharm; 2020 Sep; 46(9):1495-1506. PubMed ID: 32804005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions.
    Brewster ME; Vandecruys R; Peeters J; Neeskens P; Verreck G; Loftsson T
    Eur J Pharm Sci; 2008 Jul; 34(2-3):94-103. PubMed ID: 18420390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of machine learning models of β-cyclodextrin and sulfobutylether-β-cyclodextrin complexation free energies.
    Merzlikine A; Abramov YA; Kowsz SJ; Thomas VH; Mano T
    Int J Pharm; 2011 Oct; 418(2):207-16. PubMed ID: 21497190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfobutylether-β-cyclodextrin: A functional biopolymer for drug delivery applications.
    Pardeshi CV; Kothawade RV; Markad AR; Pardeshi SR; Kulkarni AD; Chaudhari PJ; Longhi MR; Dhas N; Naik JB; Surana SJ; García MC
    Carbohydr Polym; 2023 Feb; 301(Pt B):120347. PubMed ID: 36446486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclodextrins in drug delivery.
    Loftsson T; Jarho P; Másson M; Järvinen T
    Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of sarpogrelate external preparation for intractable pain control. I. Pre-formulation study on application of modified beta-cyclodextrins.
    Hanawa K; Hanawa T; Tsuchiya C; Higashi K; Suzuki M; Moribe K; Yamamoto K; Oguchi T
    Chem Pharm Bull (Tokyo); 2010 Jan; 58(1):45-50. PubMed ID: 20045965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of excipient based solubility increases using the CheqSol method.
    Etherson K; Halbert G; Elliott M
    Int J Pharm; 2014 Apr; 465(1-2):202-9. PubMed ID: 24513529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin derivatives in pharmaceutics.
    Albers E; Müller BW
    Crit Rev Ther Drug Carrier Syst; 1995; 12(4):311-37. PubMed ID: 9501966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of sodium sulfobutylether-β-cyclodextrin based on encapsulation.
    Huang J; Wang X; Huang T; Yang Y; Tu J; Zou J; Yang H; Yang R
    Carbohydr Polym; 2024 Jun; 333():121985. PubMed ID: 38494236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled porosity-osmotic pump pellets of a poorly water-soluble drug using sulfobutylether-beta-cyclodextrin, (SBE) 7M-beta-CD, as a solubilizing and osmotic agent.
    Sotthivirat S; Haslam JL; Stella VJ
    J Pharm Sci; 2007 Sep; 96(9):2364-74. PubMed ID: 17497739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization of drugs using beta-cyclodextrin: Experimental data and modeling.
    Kaboudi N; Asl SG; Nourani N; Shayanfar A
    Ann Pharm Fr; 2024 Jun; 82(4):663-672. PubMed ID: 38340807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward the development of an injectable dosage form of propofol: preparation and evaluation of propofol-sulfobutyl ether 7-beta-cyclodextrin complex.
    Babu MK; Godiwala TN
    Pharm Dev Technol; 2004 Aug; 9(3):265-75. PubMed ID: 15458232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cyclodextrin solubilization of drugs.
    Loftsson T; Hreinsdóttir D; Másson M
    Int J Pharm; 2005 Sep; 302(1-2):18-28. PubMed ID: 16099118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilizing excipients in oral and injectable formulations.
    Strickley RG
    Pharm Res; 2004 Feb; 21(2):201-30. PubMed ID: 15032302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: Characterization of electrospun- and lyophilized formulations.
    Szente L; Puskás I; Sohajda T; Varga E; Vass P; Nagy ZK; Farkas A; Várnai B; Béni S; Hazai E
    Carbohydr Polym; 2021 Jul; 264():118011. PubMed ID: 33910715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of sulfobutylether-beta-cyclodextrin on the stability of S- and R- omeprazole.
    Agatonovic-Kustrin S; Williams D; Ibrahim N; Glass BD
    Curr Drug Discov Technol; 2007 Oct; 4(3):192-7. PubMed ID: 17986001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrin-Based Supramolecular Ternary Complexes: Emerging Role of Ternary Agents on Drug Solubility, Stability, and Bioavailability.
    Suvarna P; Chaudhari P; Lewis SA
    Crit Rev Ther Drug Carrier Syst; 2022; 39(5):1-50. PubMed ID: 35993995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
    Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.